MPO and Cerebral ischemia: In STZ-induced diabetic rats, liraglutide showed its protective effects on brain nerve cells against cerebral ischemia by activating the Nrf2/HO-1 pathway and promoting the activities of other antioxidant enzymes, including SOD and myeloperoxidase (MPO) [55].